Efficacy of topical cyclosporine for the treatment of ocular rosacea
- 308 Downloads
This study was designed to compare the efficacy of cyclosporine ophthalmic emulsion 0.05% with an artificial tear solution for the treatment of rosacea-associated eyelid and corneal pathology.
Double-masked, randomized, 3-month clinical trial of 37 patients with rosacea-associated eyelid and corneal changes (defined as lid margin telangiectasia, meibomian gland inspissation, and/or fullness of the lid margin). All findings were standardized and compared to photographs for grading.
There was a statistically significant increase in Schirmer (with anesthesia) scores of 2.7±2.2 mm after 3 months of treatment in the topical cyclosporine group (P<0.001), compared with a mean decrease of −1.4±4.6 mm (P=0.271) in the artificial tears group. The mean tear break-up time score significantly improved in the topical cyclosporine group (mean increase of 3.56±1.5 seconds, P<0.001), but worsened in the control group, although this change was not significantly significant (mean decrease of −0.04±1.6 seconds, P=0.929). The topical cyclosporine group exhibited a significantly greater mean reduction in corneal staining scores (−1.3±0.53) compared with the control group (−0.2±0.83; between groups P<0.001). The topical cyclosporine group had a greater improvement in Ocular Surface Disease Index scores than those using artificial tears (P=0.022). Limitations of the study included an older, predominantly Caucasian patient population and short trial length.
Topical cyclosporine 0.05% is more effective than artificial tears for the treatment of rosacea-associated lid and corneal changes.
Keywordsartificial tears cyclosporine meibomian gland ocular rosacea telangiectasia
Unable to display preview. Download preview PDF.
- 4.Bowman RW, McCulley JP, Jester JV. Meibomian gland dysfunction and rosacea. In: Pepose J, Holland G, Wilhelmus K, eds. Ocular Infection and Immunity. St. Louis: Mosby-Year Book; 1996:334–343.Google Scholar
- 11.Randleman JB, Loft E, Song CD. Ocular rosacea. Available at: http://www.emedicine.com/oph/topic115.htm. Accessed Nov. 7, 2006.
- 14.Restasis [package insert]. CA: Allergan Inc.; 2004.Google Scholar
- 22.Perry HD, Wittpenn JR, D’Aversa G, Donnenfeld ED. Topical cyclosporine 0.05% for the treatment of chronic, active ocular rosacea. Poster presented at: Annual Meeting of the Association for Research in Vision and Ophthalmology; May 3, 2005; Ft. Lauderdale, Florida, USA.Google Scholar